Regenerx Biopharmaceuticals (RGRX) Stock Price, News & Analysis
Company Description
Regenerx Biopharmaceuticals (OTC Link: RGRX) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $299.0.
RGRX has gained 450.0% over the past year. Shares last traded at $0.0011.
For FY2022, Regenerx Biopharmaceuticals reported revenue of $77K with net income of -$1.7M and diluted earnings per share of -$0.01. The company operates at a net profit margin of -2250.4%.
This page collects what Stock Titan holds for RGRX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Regenerx Biopharmaceuticals (RGRX) stock last closed at $0.0011. Over the past 12 months, the stock has gained 450.0%. At a market capitalization of $299.0, RGRX is classified as a micro-cap stock with approximately 1.5M shares outstanding.
Latest News
Regenerx Biopharmaceuticals has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include stock split, clinical trial, fda approval. View all RGRX news →
SEC Filings
Financial Highlights
Regenerx Biopharmaceuticals generated $77K in revenue in FY2022, operating income reached -$1.4M (-1826.4% operating margin), and net income was -$1.7M, reflecting a -2250.4% net profit margin. Diluted earnings per share stood at -$0.01. The company generated -$941K in operating cash flow. With a current ratio of 0.55, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
RGRX Company Profile & Sector Positioning
Regenerx Biopharmaceuticals (RGRX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing RGRX often look at related companies in the same sector, including Neximmune, Inc. (NEXI), Eloxx Pharmaceut (ELOX), Effector Therapeutics Inc (EFTR), Innoveren Scientific Inc (IVRN), and Gritstone Bio Inc (GRTSQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RGRX's relative position within its industry.